Actively Recruiting
A Preliminary Study Evaluating an N-of-1 Protocol for Personalized Beta-Blocker Use in Older Adults with Heart Failure with Preserved Ejection Fraction
Led by Weill Medical College of Cornell University · Updated on 2026-08-21
18
Participants Needed
1
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating an approach called N-of-1 trials to help older adults with Heart Failure with Preserved Ejection Fraction HFpEF decide whether to continue or stop taking beta-blocker medications. This Phase 4 behavioral intervention study uses a single participant crossover design to understand how this personalized method can improve confidence in medication decisions, addressing challenges in deprescribing beta-blockers for this condition. Participants undergo a randomized sequence of treatment periods where beta-blockers are either taken On or gradually reduced and stopped Off. Each participant experiences up to 6 periods lasting up to 6 weeks each, arranged in either ABAB or BABA order. During On periods, they take their usual or highest tolerable beta-blocker dose, and during Off periods, the dose is reduced by 50% weekly until stopped or at lowest tolerable dose. Participants may choose to continue for additional periods to gather more information before deciding. Throughout the study, participants are assessed using interviews and standardized questionnaires to measure their confidence and decision-making about beta-blocker use. Outcomes include changes in confidence, feeling informed, uncertainty, support, decision effectiveness, shared decision making, and patient activation, tracked for up to 88 weeks. The study also evaluates the feasibility of using this N-of-1 trial method for medication adjustment in this population.
CONDITIONS
Brief Title
A Preliminary Study for INFORMED
Research Team
S
Srikar Savaram, BS
P
Parag Goyal, MD, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here